Restricted accessResearch articleFirst published online 2025
Effective atomic number and electron density from dual-energy CT for differentiating malignant gliomas: Validation using the World Health Organization 2021 brain tumor classification
Based on the World Health Organization (WHO) 2021 brain tumor pathology classification, we evaluated the usefulness of dual-energy CT (DECT) for differentiating malignancy grades in malignant gliomas and examined its correlation with amide proton transfer (APT). A prospective observational study was conducted on 49 patients: 16 with glioblastoma (GBM, grade 4), 13 with astrocytoma (A3, grade 3), 10 with oligodendroglioma (O3, grade 3), and 10 with oligodendroglioma (O2, grade 2). Effective atomic number (Zeff) and electron density (ED) from DECT were analyzed for tumor grade differentiation and correlation with APT. High-grade gliomas, which are influenced by vascular endothelial growth factor (VEGF) and microvascular proliferation, showed significant differences and correlations in post-contrast Zeff. A correlation between Zeff and MIB-1 suggests its potential as an indicator of cell proliferation. Additionally, correlations between Zeff and APT, as well as between ED and APT, indicate that DECT may be useful for grading malignant gliomas.
WatanabeAMuragakiYMaruyamaT, et al.Usefulness of 11 C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions. J Neuro Oncol2016; 126: 577–583.
2.
LeeMDJainRGalbraithK, et al.T2-FLAIR mismatch sign predicts DNA methylation subclass and CDKN2A/B status in IDH-mutant astrocytomas. Clin Cancer Res2024; 30: 3512–3519.
3.
ShibaharaIKumabeT. Glioblastoma, IDH-wildtype. No shinkei geka. Neurolog Surg2023; 51: 821–828.
4.
TatsugamiFHigakiTNakamuraY, et al.Dual-energy CT: minimal essentials for radiologists. Jpn J Radiol2022; 40: 547–559.
5.
KaichiYTatsugamiFNakamuraY, et al.Improved differentiation between high-and low-grade gliomas by combining dual-energy CT analysis and perfusion CT. Medicine2018; 97: e11670.
6.
LvYZhouJLvX, et al.Dual-energy spectral CT quantitative parameters for the differentiation of Glioma recurrence from treatment-related changes: a preliminary study. BMC Med Imag2020; 20: 5–7.
7.
JonesCKSchlosserMJVan ZijlPC, et al.Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med2006; 56: 585–592.
8.
WardKMAletrasAHBalabanRS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson2000; 143: 79–87.
9.
TogaoOHiwatashiAYamashitaK, et al.Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion-and perfusion-weighted imaging. Eur Radiol2017; 27: 578–588.
10.
TogaoOYoshiuraTKeuppJ, et al.Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol2014; 16: 441–448.
11.
Van ZijlPCYadavNN. Chemical exchange saturation transfer (CEST): what is in a name and what isn't?Magn Reson Med2011; 65: 927–948.
12.
ZhouJBlakeleyJOHuaJ, et al.Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med2008; 60: 842–849.
13.
KamimuraKNakajoMYoneyamaT, et al.Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions. Jpn J Radiol2019; 37: 109–116.
14.
WuBWarnockGZaissM, et al.An overview of CEST MRI for non-MR physicists. EJNMMI Phys2016; 3: 19–21.
15.
KawaharaDOzawaSYokomachiK, et al.Synthesized effective atomic numbers for commercially available dual-energy CT. Rep Practical Oncol Radiother2020; 25: 692–697.
16.
SchaefferCJLeonSMOlguinCA, et al.Accuracy and reproducibility of effective atomic number and electron density measurements from sequential dual energy CT. Med Phys2021; 48: 3525–3539.
17.
BotweBOSchandorfCInkoomS, et al.National indication-based diagnostic reference level values in computed tomography: preliminary results from Ghana. Phys Med2021; 84: 274–284.
18.
ZhengFChenBZhangL, et al.Radiogenomic analysis of vascular endothelial growth factor in patients with glioblastoma. J Comput Assist Tomogr2023; 47: 967–972.
19.
ChakrabartiRGuptaVVyasS, et al.Correlation of dual energy computed tomography electron density measurements with cerebral glioma grade. NeuroRadiol J2022; 35: 352–362.
20.
XuJShengYLiH, et al.A data-driven intravoxel mean diffusivities distribution approach for molecular classifications and MIB-1 prediction of gliomas. Med Phys2024; 51: 7332–7344.
21.
StadnykLNosykOTonkopiE, et al.Survey of computed tomography practice in Ukraine and establishment of national diagnostic reference levels for most common CT examinations of adults. Radiat Protect Dosim2023; 199: 1142–1150.
22.
AlhujailiSFAlshabibiASAlaferF, et al.Establishment of local diagnostic reference levels for head CT imaging in the madina region, Saudi Arabia. Diagnostics2024; 14: 2882.
23.
ZhangHWZhangHBLiuXL, et al.Clinical assessment of magnetic resonance spectroscopy and diffusion-weighted imaging in diffuse glioma: insights into histological grading and IDH classification. Can Assoc Radiol J2024; 75: 868–877.
24.
ZhaoKHuangHGaoE, et al.Distributed parameter model of dynamic contrast-enhanced MRI in the identification of IDH mutation, 1p19q codeletion, and tumor cell proliferation in glioma patients. Front Oncol2024; 14: 1333798.
25.
WangKLiYChengH, et al.Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status. BMC Neurol2021; 21: 460.
26.
FliesCMSnijdersTJVan SeetersT, et al.Perfusion imaging with arterial spin labeling (ASL)–MRI predicts malignant progression in low-grade (WHO grade II) gliomas. Neuroradiology2021; 63: 2023–2033.
27.
SaitoTMaruyamaTMuragakiY, et al.11C-methionine uptake correlates with combined 1p and 19q loss of heterozygosity in oligodendroglial tumors. Am J Neuroradiol2013; 34: 85–91.
